a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.
Industry Biotechnology
A.I.dvisor indicates that over the last year, EDSA has been loosely correlated with AKRO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if EDSA jumps, then AKRO could also see price increases.
Ticker / NAME | Correlation To EDSA | 1D Price Change % | ||
---|---|---|---|---|
EDSA | 100% | -4.44% | ||
AKRO - EDSA | 37% Loosely correlated | -4.45% | ||
ETNB - EDSA | 27% Poorly correlated | -7.58% | ||
HRMY - EDSA | 23% Poorly correlated | +1.03% | ||
IPSC - EDSA | 22% Poorly correlated | -6.82% | ||
NCNA - EDSA | 21% Poorly correlated | -7.10% | ||
More |
Ticker / NAME | Correlation To EDSA | 1D Price Change % |
---|---|---|
EDSA | 100% | -4.44% |
north america theme (189 stocks) | 6% Poorly correlated | -0.16% |